MARRA, ALBERTO MARIA
 Distribuzione geografica
Continente #
AS - Asia 6.617
NA - Nord America 5.447
EU - Europa 4.313
SA - Sud America 870
AF - Africa 180
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.436
Nazione #
US - Stati Uniti d'America 5.211
SG - Singapore 2.829
RU - Federazione Russa 1.927
VN - Vietnam 1.337
CN - Cina 1.165
IT - Italia 925
BR - Brasile 681
HK - Hong Kong 528
DE - Germania 366
FR - Francia 238
NL - Olanda 195
UA - Ucraina 151
FI - Finlandia 136
BD - Bangladesh 129
IN - India 128
CA - Canada 111
JP - Giappone 105
GB - Regno Unito 104
AR - Argentina 86
MX - Messico 69
KR - Corea 63
CI - Costa d'Avorio 54
IQ - Iraq 45
AT - Austria 44
ZA - Sudafrica 44
PH - Filippine 42
IE - Irlanda 41
ES - Italia 39
SE - Svezia 34
TH - Thailandia 34
ID - Indonesia 33
PL - Polonia 29
EC - Ecuador 27
TR - Turchia 27
CO - Colombia 26
PK - Pakistan 23
VE - Venezuela 19
TW - Taiwan 17
JO - Giordania 16
JM - Giamaica 14
KE - Kenya 14
MA - Marocco 14
UZ - Uzbekistan 12
BE - Belgio 11
DZ - Algeria 11
MY - Malesia 11
CZ - Repubblica Ceca 10
LT - Lituania 10
BG - Bulgaria 9
PY - Paraguay 9
CL - Cile 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CR - Costa Rica 7
EG - Egitto 7
HN - Honduras 7
KZ - Kazakistan 7
PE - Perù 6
RS - Serbia 6
IL - Israele 5
KG - Kirghizistan 5
LB - Libano 5
NP - Nepal 5
RO - Romania 5
UY - Uruguay 5
AO - Angola 4
AU - Australia 4
BH - Bahrain 4
CG - Congo 4
GA - Gabon 4
GR - Grecia 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
DK - Danimarca 3
ET - Etiopia 3
GE - Georgia 3
NE - Niger 3
PA - Panama 3
SI - Slovenia 3
TN - Tunisia 3
UG - Uganda 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
CU - Cuba 2
CV - Capo Verde 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
NI - Nicaragua 2
Totale 17.394
Città #
Singapore 1.355
San Jose 972
Ashburn 577
Hong Kong 505
Moscow 456
Ho Chi Minh City 372
Beijing 325
Chandler 324
Hanoi 300
Hefei 280
Naples 268
Santa Clara 205
Munich 188
Millbury 163
Los Angeles 152
The Dalles 152
Amsterdam 141
Lauterbourg 135
Dallas 128
Tokyo 92
Des Moines 86
New York 86
Lawrence 81
Redondo Beach 77
São Paulo 72
Buffalo 66
Helsinki 59
Haiphong 58
Napoli 55
Boston 50
Seoul 48
Da Nang 47
Frankfurt am Main 47
Nanjing 47
Chicago 43
Orem 40
Council Bluffs 39
Princeton 39
Milan 37
Turku 36
Rome 34
Seattle 33
Brooklyn 32
Mexico City 29
Toronto 29
Nuremberg 28
Pune 28
Phoenix 27
Houston 26
Wilmington 25
Atlanta 24
Montreal 24
Stockholm 24
Denver 21
Ottawa 21
Vienna 21
London 20
Poplar 20
Warsaw 20
Washington 20
Dhaka 19
Guangzhou 19
Castellón 18
Rio de Janeiro 18
Johannesburg 17
Amman 16
Chennai 16
Düsseldorf 15
Porto Alegre 15
Belo Horizonte 14
Biên Hòa 14
Bogotá 14
Falkenstein 14
Manchester 14
Mumbai 14
Quảng Ngãi 14
Salerno 14
Bangkok 13
Nairobi 13
Tianjin 13
Baghdad 12
Can Tho 12
Dong Ket 12
Dublin 12
New Delhi 12
Pomigliano d'Arco 12
Brussels 11
Changsha 11
Hải Dương 11
Ribeirão Preto 11
San Francisco 11
Tashkent 11
Thái Nguyên 11
Ankara 10
Da Lat 10
Dearborn 10
Salt Lake City 10
Bari 9
Bexley 9
Bắc Giang 9
Totale 9.229
Nome #
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 342
Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives 223
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 220
Carotid plaque detection improves the predictive value of CHA(2)DS(2)-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study 217
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 202
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice 193
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 193
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 188
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 187
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 184
Bowel Angiodysplasia and Myocardial Infarction secondary to an ischaemic imbalance: A case report 179
Klinefelter syndrome, cardiovascular system, and thromboembolic disease: Review of literature and clinical perspectives 179
The Right Heart International Network (RIGHT-NET): Rationale, Objectives, Methodology, and Clinical Implications 172
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry 171
Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction 166
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 165
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure 162
Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure. Part II 161
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 161
Growth hormone deficiency is associated with worse cardiac function, physical performance, and outcome in chronic heart failure: Insights from the T.O.S.CA. GHD study 158
Acute Heart Failure: Diagnostic-Therapeutic Pathways and Preventive Strategies-A Real-World Clinician's Guide 155
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 154
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 153
Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction 153
Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis 152
Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study 150
Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis: An Exercise Two-Dimensional Speckle Tracking Doppler Echocardiography Study 149
Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways 148
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 148
IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry 147
A multicentric quality-control study of exercise Doppler echocardiography of the right heart and the pulmonary circulation. The RIGHT Heart International NETwork (RIGHT-NET) 147
Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure 146
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 145
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 145
Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET) 144
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry 143
The T.O.S.CA. Project: research, education and care. 142
Growth Hormone as Biomarker in Heart Failure 142
Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. 141
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 139
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 138
Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry 135
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure (Endocrine, (2019), 65, 3, (714-716), 10.1007/s12020-019-01993-y) 135
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry 135
The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy 134
Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment 134
Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension 133
Human heart shifts from IGF-1 production to utilization with chronic heart failure 132
Effetti della terapia sostitutiva con GH sui parametri funzionali e di struttura cardiovascolare in pazienti con scompenso cardiaco e deficit di GH 132
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. 131
Reference ranges for and determinants of right ventricular area in healthy adults by two-dimensional echocardiography 131
Right Heart Pulmonary Circulation Unit Response to Exercise in Patients with Controlled Systemic Arterial Hypertension: Insights from the RIGHT Heart International NETwork (RIGHT-NET) 131
Can pulse wave velocity (PWV) alone express arterial stiffness? A neglected tool for vascular function assessment 130
Cardiovascular abnormalities in Klinefelter Syndrome 129
Bleeding management in patients on new oral anticoagulants 129
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 128
Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry 128
Combined effects of growth hormone and testosterone replacement treatment in heart failure 127
Anabolic hormones and heart failure with preserved ejection fraction: looking for Ariadne's thread 126
Gender-related differences in pulmonary arterial hypertension targeted drugs administration 125
Differences in the efficacy and safety of the COVID-19 vaccination campaign in males and females. Does only sex matter? 124
Prospettive di intervento della riabilitazione cardiologica sulla qualità della vita nei pazienti con scompenso cardiaco cronico e deficit di GH. 123
Physiologic correlates of tricuspid annular plane systolic excursion in 1168 healthy subjects 123
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 123
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit 122
Biomarkers in Pulmonary Hypertension 121
Growth Hormone Therapy in Heart Failure 121
Testosterone treatment in chronic heart failure. Review of literature and future perspectives 117
Reference ranges and determinants of right ventricle outflow tract acceleration time in healthy adults by two-dimensional echocardiography 116
Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre 116
Role of Cardiac Magnetic Resonance Imaging in Heart Failure 116
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 115
Reference values and determinants of right ventricle outflow tract acceleration time in healthy adults by two-dimensional echocardiography 114
Metabolic Syndrome in Heart Failure: Friend or Foe? 113
Modulating NO–GC Pathway in Pulmonary Arterial Hypertension 112
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction 112
What have we learned so far from the sex/gender issue in heart failure? An overview of current evidence 110
Imaging the right heart pulmonary circulation unit: Insights from advanced ultrasound techniques 110
Sex and gender specific pitfalls and challenges in cardiac rehabilitation: a working hypothesis towards better inclusivity in cardiac rehabilitation programmes. 108
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 107
An unusual case of dilated cardiomyopaty associated with partial hypopituitarism. 106
When Pulmonary Hypertension Complicates Heart Failure 106
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 104
Cardiac Rehabilitation and Acute Aortic Dissection: Understanding and Addressing the Evidence GAP A Systematic Review 104
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction 103
Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS 103
Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure: Part I 101
Glucose Metabolism Abnormalities in Heart Failure Patients: Insights and Prognostic Relevance. 101
The dual relationship between polypharmacy and frailty in nursing home residents: polypharmacy as a cause or a consequence? 98
Clinical features and management of venous thromboembolism in patients with Behçet’s syndrome: a single-center case–control study 96
Postoperative myocardial injury: Trying to square the circle 95
A focused review of gender differences in antithrombotic therapy 94
CT score in COVID-19-related pneumonia, the radiologist, and the internist. Trying to unmask who is “the good”, who is “the bad” and who is “the ugly” 94
Awareness of sex and gender dimensions among physicians: the European federation of internal medicine assessment of gender differences in Europe (EFIM-IMAGINE) survey 94
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 91
Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure 91
The impact of gender in cardiovascular medicine: Lessons from the gender/sex-issue in heart failure 89
Age-changes in right ventricular function–pulmonary circulation coupling: from pediatric to adult stage in 1899 healthy subjects. The RIGHT Heart International NETwork (RIGHT-NET) 89
Biomarkers in Heart Failure: Clinical Insights 89
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 87
Totale 13.647
Categoria #
all - tutte 58.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022684 10 7 19 6 8 7 23 19 58 76 159 292
2022/2023947 121 53 32 21 110 86 71 82 145 143 60 23
2023/2024913 33 115 131 89 46 117 15 115 17 27 127 81
2024/20254.730 233 252 27 69 105 237 515 318 413 478 1.629 454
2025/20269.471 967 754 976 756 1.531 445 1.238 593 1.167 548 222 274
2026/2027221 221 0 0 0 0 0 0 0 0 0 0 0
Totale 17.777